Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants
Open Access
- 14 October 1999
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 341 (16) , 1190-1196
- https://doi.org/10.1056/nejm199910143411604
Abstract
Antenatal glucocorticoid therapy decreases the incidence of several complications among very premature infants. However, its effect on the occurrence of cystic periventricular leukomalacia, a major cause of cerebral palsy, remains unknown.Keywords
This publication has 19 references indexed in Scilit:
- Obstetric risk factors for periventricular leukomalacia among preterm infantsBJOG: An International Journal of Obstetrics and Gynaecology, 1998
- PERIVENTRICULAR LEUKOMALACIA: RISK FACTORS REVISITEDDevelopmental Medicine and Child Neurology, 1996
- Scientific basis and therapeutic regimens for use of antenatal glucocorticoidsAmerican Journal of Obstetrics and Gynecology, 1995
- Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972 to 1994American Journal of Obstetrics and Gynecology, 1995
- Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal OutcomesJAMA, 1995
- Best Subsets Logistic RegressionBiometrics, 1989
- Predictors of low and very low birth weight and the relation of these to cerebral palsyJAMA, 1985
- An International Classification of Retinopathy of PrematurityArchives of Ophthalmology (1950), 1984
- Necrotizing EnterocolitisNew England Journal of Medicine, 1984
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978